HomeCompareCXBMF vs MRK

CXBMF vs MRK: Dividend Comparison 2026

CXBMF yields 92.17% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CXBMF wins by $2.76M in total portfolio value
10 years
CXBMF
CXBMF
● Live price
92.17%
Share price
$2.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.81M
Annual income
$897,478.47
Full CXBMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CXBMF vs MRK

📍 CXBMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCXBMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CXBMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CXBMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CXBMF
Annual income on $10K today (after 15% tax)
$7,834.10/yr
After 10yr DRIP, annual income (after tax)
$762,856.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CXBMF beats the other by $754,528.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CXBMF + MRK for your $10,000?

CXBMF: 50%MRK: 50%
100% MRK50/50100% CXBMF
Portfolio after 10yr
$1.43M
Annual income
$453,638.30/yr
Blended yield
31.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CXBMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
2.6
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CXBMF buys
0
MRK buys
0
No recent congressional trades found for CXBMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCXBMFMRK
Forward yield92.17%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.81M$56.8K
Annual income after 10y$897,478.47$9,798.13
Total dividends collected$2.49M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CXBMF vs MRK ($10,000, DRIP)

YearCXBMF PortfolioCXBMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,917$9,216.59$11,206$366.19+$8.7KCXBMF
2$38,466$17,155.42$12,650$502.35+$25.8KCXBMF
3$72,125$30,965.76$14,407$694.19+$57.7KCXBMF
4$131,436$54,262.79$16,585$967.82+$114.9KCXBMF
5$233,053$92,416.55$19,342$1,363.89+$213.7KCXBMF
6$402,513$153,146.25$22,913$1,947.19+$379.6KCXBMF
7$677,889$247,199.53$27,662$2,823.89+$650.2KCXBMF
8$1,114,424$389,082.88$34,159$4,173.35+$1.08MCXBMF
9$1,790,226$597,792.36$43,337$6,308.80+$1.75MCXBMF
10$2,813,020$897,478.47$56,776$9,798.13+$2.76MCXBMF

CXBMF vs MRK: Complete Analysis 2026

CXBMFStock

Calibre Mining Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties. It primarily explores for gold, silver, and copper deposits. The company holds 100% interests in the El Limon and La Libertad gold mines, the Pavon gold project, and other mineral concessions in Nicaragua, Central America; and the Borosi Gold-Silver-Copper project located in the North Atlantic Autonomous Region of Nicaragua, Central America. It also holds 100% interests in the Pan Mine gold project, the Gold Rock project, and the Illipah Gold project in Nevada, the United States, as well as the Golden Eagle project in Washington State, the United States. The company was formerly known as TLC Ventures Corp. and changed its name to Calibre Mining Corp. in June 2007. Calibre Mining Corp. was founded in 1969 and is headquartered in Vancouver, Canada.

Full CXBMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CXBMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CXBMF vs SCHDCXBMF vs JEPICXBMF vs OCXBMF vs KOCXBMF vs MAINCXBMF vs JNJCXBMF vs ABBVCXBMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.